MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 161 to 180 of 166,322 approvalsPage 9 of 8317

Famitinib Malate Capsules

Approval Number: 国药准字H20250022
Registration: May 27, 2025
江苏恒瑞医药股份有限公司

Progesterone Injection（II）

Approval Number: 国药准字H20254257
Registration: May 27, 2025
北京品尚品医药科技有限公司

Potassium Aspartate Injection

Approval Number: 国药准字H20254272
Registration: May 27, 2025
昆明南疆制药有限公司

Isavuconazonium Sulfate for Injection

Approval Number: 国药准字H20254299
Registration: May 27, 2025
华北制药股份有限公司

Icosapent Ethyl Soft Capsules

Approval Number: 国药准字H20254286
Registration: May 27, 2025
山东新华制药股份有限公司

Metformin Hydrochloride Sustained-release Tablets

Approval Number: 国药准字H20254325
Registration: May 27, 2025
浙江众延医药科技有限公司

Tofacitinib Citrate Tablets

Approval Number: 国药准字H20254279
Registration: May 27, 2025
浙江施强制药有限公司

Icosapent Ethyl Soft Capsules

Approval Number: 国药准字H20254287
Registration: May 27, 2025
山东新华制药股份有限公司

Nimodipine Injection

Approval Number: 国药准字H20254269
Registration: May 27, 2025
成都米子生物医药科技有限公司

Levofloxacin and Sodium Chloride Injection

Approval Number: 国药准字H20254335
Registration: May 27, 2025
成都克莱蒙医药科技有限公司

Celecoxib Tablets

Approval Number: 国药准字H20254316
Registration: May 27, 2025
江西施美药业股份有限公司

Cobamamide Capsules

Approval Number: 国药准字H20254385
Registration: May 27, 2025
北京星昊医药股份有限公司

Ibuprofen Granules

Approval Number: 国药准字H20254259
Registration: May 27, 2025
四川依科制药有限公司

Ceftizoxime Sodium for Injection

Approval Number: 国药准字H20254298
Registration: May 27, 2025
广东金城金素制药有限公司

Haloperidol Tablets

Approval Number: 国药准字H20254337
Registration: May 27, 2025
浙江京新药业股份有限公司

Gliclazide Sustained-release Tablets

Approval Number: 国药准字H20254382
Registration: May 27, 2025
山东汇泽生物制药有限公司

Betamethasone Sodium Phosphate Injection

Approval Number: 国药准字H20254262
Registration: May 27, 2025
汇禹远和（海南）药业有限公司

Potassium Chloride Granules

Approval Number: 国药准字H20254314
Registration: May 27, 2025
南京海纳制药有限公司

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.